全文获取类型
收费全文 | 39489篇 |
免费 | 2819篇 |
国内免费 | 127篇 |
专业分类
耳鼻咽喉 | 283篇 |
儿科学 | 1408篇 |
妇产科学 | 798篇 |
基础医学 | 5088篇 |
口腔科学 | 1525篇 |
临床医学 | 3947篇 |
内科学 | 7288篇 |
皮肤病学 | 519篇 |
神经病学 | 4085篇 |
特种医学 | 1539篇 |
外国民族医学 | 8篇 |
外科学 | 5908篇 |
综合类 | 471篇 |
一般理论 | 56篇 |
预防医学 | 2934篇 |
眼科学 | 1349篇 |
药学 | 2784篇 |
中国医学 | 53篇 |
肿瘤学 | 2392篇 |
出版年
2021年 | 466篇 |
2020年 | 331篇 |
2019年 | 537篇 |
2018年 | 653篇 |
2017年 | 533篇 |
2016年 | 564篇 |
2015年 | 620篇 |
2014年 | 897篇 |
2013年 | 1481篇 |
2012年 | 2204篇 |
2011年 | 2458篇 |
2010年 | 1346篇 |
2009年 | 1294篇 |
2008年 | 2376篇 |
2007年 | 2643篇 |
2006年 | 2565篇 |
2005年 | 2583篇 |
2004年 | 2488篇 |
2003年 | 2386篇 |
2002年 | 2300篇 |
2001年 | 527篇 |
2000年 | 456篇 |
1999年 | 462篇 |
1998年 | 451篇 |
1997年 | 397篇 |
1996年 | 309篇 |
1995年 | 394篇 |
1994年 | 366篇 |
1993年 | 359篇 |
1992年 | 424篇 |
1991年 | 400篇 |
1990年 | 381篇 |
1989年 | 374篇 |
1988年 | 339篇 |
1987年 | 350篇 |
1986年 | 360篇 |
1985年 | 343篇 |
1984年 | 446篇 |
1983年 | 360篇 |
1982年 | 396篇 |
1981年 | 362篇 |
1980年 | 380篇 |
1979年 | 283篇 |
1978年 | 292篇 |
1977年 | 280篇 |
1976年 | 230篇 |
1975年 | 221篇 |
1974年 | 220篇 |
1973年 | 210篇 |
1972年 | 165篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Dursun Furkan Elshabrawy Ahmed Wang Hanzhang Rodriguez Ronald Liss Michael A. Kaushik Dharam Gelfond Jonathan Mansour Ahmed M. 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(6):1068-1076
International Journal of Clinical Oncology - A recently reported phase III randomized trial comparing open and minimally invasive hysterectomy showed significantly higher rates of local recurrence... 相似文献
6.
7.
Samir Gupta MD MSCS Gloria D. Coronado PhD Keith Argenbright MD Alison T. Brenner PhD MPH Sheila F. Castañeda PhD Jason A. Dominitz MD MHS Beverly Green MD MPH Rachel B. Issaka MD MAS Theodore R. Levin MD Daniel S. Reuland MD MPH Lisa C. Richardson MD MPH Douglas J. Robertson MD MPH Amit G. Singal MD MS Michael Pignone MD MPH 《CA: a cancer journal for clinicians》2020,70(4):283-298
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented. 相似文献
8.
RongZong Liu WonShik Choi Saket Jain Deepak Dinakaran Xia Xu Woo Hyun Han XiaoHong Yang Darryl D. Glubrecht Ronald B. Moore Hlne Lemieux Roseline Godbout 《Molecular oncology》2020,14(12):3100
Early stage localized prostate cancer (PCa) has an excellent prognosis; however, patient survival drops dramatically when PCa metastasizes. The molecular mechanisms underlying PCa metastasis are complex and remain unclear. Here, we examine the role of a new member of the fatty acid‐binding protein (FABP) family, FABP12, in PCa progression. FABP12 is preferentially amplified and/or overexpressed in metastatic compared to primary tumors from both PCa patients and xenograft animal models. We show that FABP12 concurrently triggers metastatic phenotypes (induced epithelial‐to‐mesenchymal transition (EMT) leading to increased cell motility and invasion) and lipid bioenergetics (increased fatty acid uptake and accumulation, increased ATP production from fatty acid β‐oxidation) in PCa cells, supporting increased reliance on fatty acids for energy production. Mechanistically, we show that FABP12 is a driver of PPARγ activation which, in turn, regulates FABP12''s role in lipid metabolism and PCa progression. Our results point to a novel role for a FABP‐PPAR pathway in promoting PCa metastasis through induction of EMT and lipid bioenergetics.
Abbreviations
- AR
- androgen receptor
- ATP
- adenosine triphosphate
- CN
- copy number
- CPT1
- carnitine palmitoyltransferase I
- CS
- citrate synthase
- EMT
- epithelial–mesenchymal transition
- ET
- electron transfer‐state
- FABP
- fatty acid‐binding protein
- LD
- lipid droplet
- OA
- oleic acid
- PCa
- prostate cancer
- PPAR
- peroxisome proliferator‐activated receptor
- PPRE
- peroxisome proliferator‐activated receptor response element
- TZD
- thiazolidinediones
9.
10.